HOLLY COBB: Open Payments
NPI 1316342975 · MONTGOMERY, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,182 in 110 payments from 33 companies in 2025. Trend: 2023 $1,701 · 2024 $2,110 · 2025 $2,182
Food & beverage: $2,182
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 13 | $251 |
| Novartis Pharmaceuticals Corporation | 10 | $227 |
| Regeneron Healthcare Solutions, Inc. | 9 | $182 |
| Incyte Corporation | 10 | $161 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $131 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $110 |
| Daiichi Sankyo Inc. | 5 | $108 |
| BeOne Medicines USA, Inc. | 5 | $95 |
| Celgene Corporation | 4 | $83 |
| Merck Sharp & Dohme LLC | 4 | $78 |
Products named: LIBTAYO, Nubeqa, REBLOZYL, MONJUVI, KISQALI, BRUKINSA, TALVEY, Epkinly.
Industry payments across AL — which companies pay providers there.
